PDS Biotechnology Corporation (PDSB)
NASDAQ: PDSB · Real-Time Price · USD
1.270
-0.020 (-1.55%)
At close: May 13, 2025, 4:00 PM
1.280
+0.010 (0.79%)
Pre-market: May 14, 2025, 6:00 AM EDT
PDS Biotechnology Employees
PDS Biotechnology had 24 employees as of December 31, 2024. The number of employees decreased by 1 or -4.00% compared to the previous year.
Employees
24
Change (1Y)
-1
Growth (1Y)
-4.00%
Revenue / Employee
n/a
Profits / Employee
-$1,567,099
Market Cap
57.65M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PDSB News
- 4 days ago - PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 days ago - PDS Biotech Announces Additional Details on Two Preclinical Universal Influenza Presentations at IMMUNOLOGY2025™ Annual Meeting - GlobeNewsWire
- 6 days ago - PDS Biotech Announces Conference Call and Webcast for First Quarter 2025 Financial Results - GlobeNewsWire
- 20 days ago - PDS Biotech Announces Multiple Abstracts Selected for Presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting - GlobeNewsWire
- 27 days ago - PDS Biotech Announces Preclinical Influenza Data to be Presented in Symposium at IMMUNOLOGY2025™ Annual Meeting - GlobeNewsWire
- 5 weeks ago - PDS Biotech Announces PDS01ADC Clinical Data to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2025 - GlobeNewsWire
- 6 weeks ago - PDS Biotechnology Corporation (PDSB) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - PDS Biotech Reports Full Year 2024 Financial Results and Provides Clinical Programs Update - GlobeNewsWire